Float Short %

0.11

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.19

Price

Target Price

2.67

Analyst Recom

Performance Q

-45.29

Relative Volume

Beta

1.07

Ticker: VJET

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	VJET	0.6401	N/A	N/A	0
2025-08-18	VJET	0.6401	N/A	N/A	0
2025-08-19	VJET	0.6401	N/A	N/A	0
2025-08-20	VJET	0.6401	N/A	N/A	0
2025-08-21	VJET	0.6401	N/A	N/A	0
2025-08-22	VJET	0.6401	N/A	N/A	0
2025-08-25	VJET	0.6401	N/A	N/A	0
2025-08-26	VJET	0.6401	N/A	N/A	0
2025-08-27	VJET	0.6401	N/A	N/A	0
2025-08-28	VJET	0.6401	N/A	N/A	0
2025-08-29	VJET	0.6401	N/A	N/A	0
2025-09-02	VJET	0.6401	N/A	N/A	0
2025-09-03	VJET	0.6401	N/A	N/A	0
2025-09-04	VJET	0.6401	N/A	N/A	0
2025-09-05	VJET	0.6401	N/A	N/A	0
2025-09-08	VJET	0.6401	N/A	N/A	0
2025-09-09	VJET	0.6401	N/A	N/A	0
2025-09-10	VJET	0.6401	N/A	N/A	0
2025-09-11	VJET	0.6401	N/A	N/A	0
2025-09-12	VJET	0.6401	N/A	N/A	0
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.49

Avg. EPS Est. Next Quarter

-0.3

Insider Transactions

Institutional Transactions

80.2

Beta

1.07

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.5

Max Drawdown 5-Year %

-98.7

Target Price

2.67

P/E

Forward P/E

PEG

P/S

0.18

P/B

0.38

P/Free Cash Flow

EPS

-1.2

Average EPS Est. Cur. Y

-1.62

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-34.59

Relative Volume

Return on Equity vs Sector %

-119.2

Return on Equity vs Industry %

-106.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

stock quote shares VJET – Voxeljet AG ADR Stock Price stock today

news today VJET – Voxeljet AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch VJET – Voxeljet AG ADR yahoo finance google finance

stock history VJET – Voxeljet AG ADR invest stock market

stock prices VJET premarket after hours

ticker VJET fair value insiders trading

Float Short %

3.77

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

0.17

EPS Last/This Y

-2.07

EPS This/Next Y

0.12

Price

5.82

Target Price

14.34

Analyst Recom

Performance Q

-5.21

Relative Volume

1.06

Beta

1.11

Ticker: IMTX

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	IMTX	6.32	0.07	0.00	1541
2025-08-18	IMTX	6.21	0.09	0.00	1215
2025-08-19	IMTX	5.62	0.09	0.00	1213
2025-08-20	IMTX	5.6	0.09	0.00	1213
2025-08-21	IMTX	5.63	0.09	0.00	1213
2025-08-22	IMTX	5.68	0.09	0.00	1213
2025-08-25	IMTX	5.22	0.09	0.00	1215
2025-08-26	IMTX	5.35	0.09	0.00	1216
2025-08-27	IMTX	5.38	0.09	0.00	1218
2025-08-28	IMTX	5.26	0.09	0.00	1221
2025-08-29	IMTX	5.09	0.09	0.00	1221
2025-09-02	IMTX	5.34	0.09	0.00	1244
2025-09-03	IMTX	5.45	0.09	5.00	1245
2025-09-04	IMTX	5.72	0.09	5.00	1245
2025-09-05	IMTX	6.27	0.10	0.13	1255
2025-09-08	IMTX	5.82	0.10	4.00	1281
2025-09-09	IMTX	5.8	0.18	0.19	1406
2025-09-10	IMTX	5.82	0.19	0.00	1381
2025-09-11	IMTX	5.91	0.19	0.00	1381
2025-09-12	IMTX	5.8	0.19	0.00	1381
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	IMTX	6.33	-93.4	-	-1.83
2025-08-18	IMTX	6.21	-93.4	-	-1.83
2025-08-19	IMTX	5.59	-93.4	-	-1.83
2025-08-20	IMTX	5.61	-93.4	-	-1.83
2025-08-21	IMTX	5.62	-93.4	-	-1.83
2025-08-22	IMTX	5.68	-454.5	-	-1.91
2025-08-25	IMTX	5.23	-454.5	-	-1.91
2025-08-26	IMTX	5.35	-454.5	-	-1.91
2025-08-28	IMTX	5.28	-454.5	-	-1.91
2025-08-29	IMTX	5.08	-454.5	-	-1.91
2025-09-02	IMTX	5.34	-454.5	-	-1.91
2025-09-03	IMTX	5.45	-454.5	-	-1.91
2025-09-04	IMTX	5.73	-454.5	-	-1.91
2025-09-05	IMTX	6.26	-454.5	-	-1.91
2025-09-08	IMTX	5.81	-454.5	-	-1.91
2025-09-09	IMTX	5.78	-454.5	-	-1.91
2025-09-10	IMTX	5.81	-454.5	-	-1.91
2025-09-11	IMTX	5.92	-454.5	-	-1.91
2025-09-12	IMTX	5.82	-454.5	-	-1.91
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	IMTX	0.00	2.10	4.26
2025-08-18	IMTX	0.00	1.74	4.12
2025-08-19	IMTX	0.00	1.74	4.12
2025-08-20	IMTX	0.00	1.74	4.12
2025-08-21	IMTX	0.00	1.74	4.12
2025-08-22	IMTX	0.00	1.74	4.12
2025-08-25	IMTX	0.00	3.49	3.90
2025-08-26	IMTX	0.00	3.49	3.90
2025-08-27	IMTX	0.00	3.49	4.06
2025-08-28	IMTX	0.00	3.49	4.06
2025-08-29	IMTX	0.00	3.49	4.06
2025-09-02	IMTX	0.00	3.49	4.06
2025-09-03	IMTX	0.00	3.49	4.06
2025-09-04	IMTX	0.00	3.49	4.06
2025-09-05	IMTX	0.00	3.49	4.06
2025-09-08	IMTX	0.00	3.48	4.06
2025-09-09	IMTX	0.00	3.48	4.06
2025-09-10	IMTX	0.00	3.48	4.06
2025-09-11	IMTX	0.00	3.48	3.77
2025-09-12	IMTX	0.00	3.48	3.77
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.66

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

-0.49

Insider Transactions

Institutional Transactions

3.48

Beta

1.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

68.4

Max Drawdown 5-Year %

-77.4

Target Price

14.34

P/E

Forward P/E

PEG

P/S

5.04

P/B

1.3

P/Free Cash Flow

EPS

-0.7

Average EPS Est. Cur. Y

-1.91

EPS Next Y. (Est.)

-1.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-59.3

Relative Volume

1.06

Return on Equity vs Sector %

-41

Return on Equity vs Industry %

-27.8

EPS 1 7Days Diff

-0.5

EPS 1 30Days Diff

-0.48

EBIT Estimation

Immatics N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 554

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. was founded in 2020 and is headquartered in Tübingen, Germany.

stock quote shares IMTX – Immatics N.V Stock Price stock today

news today IMTX – Immatics N.V stock forecast ,stock prediction 2023 2024 2025

marketwatch IMTX – Immatics N.V yahoo finance google finance

stock history IMTX – Immatics N.V invest stock market

stock prices IMTX premarket after hours

ticker IMTX fair value insiders trading

FMS – Fresenius Medical Care AG ADR

Float Short %

0.25

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

0.1

EPS Last/This Y

EPS This/Next Y

1.03

Price

24.96

Target Price

29.43

Analyst Recom

2.7

Performance Q

-13.72

Relative Volume

1.08

Beta

0.91

Ticker: FMS

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	FMS	25.06	0.05	999.99	765
2025-08-18	FMS	24.83	0.03	0.40	738
2025-08-19	FMS	24.97	0.03	0.40	738
2025-08-20	FMS	25.19	0.03	1.00	745
2025-08-21	FMS	25.24	0.03	1.00	746
2025-08-22	FMS	25.6	0.03	999.99	750
2025-08-25	FMS	25.31	0.03	999.99	750
2025-08-26	FMS	25.48	0.03	999.99	750
2025-08-27	FMS	25.15	0.03	0.00	750
2025-08-28	FMS	25.18	0.03	0.00	750
2025-08-29	FMS	25.71	0.03	0.00	810
2025-09-02	FMS	24.32	0.03	0.00	810
2025-09-03	FMS	24.37	0.03	0.00	917
2025-09-04	FMS	24.32	0.03	0.00	917
2025-09-05	FMS	24.74	0.03	0.00	937
2025-09-08	FMS	25.09	0.03	0.01	1001
2025-09-09	FMS	25.3	0.02	0.28	1072
2025-09-10	FMS	24.88	0.04	0.01	1130
2025-09-11	FMS	25.28	0.03	0.36	1334
2025-09-12	FMS	24.97	0.04	0.00	1339
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	FMS	25.07	22.9	561.4	1.96
2025-08-18	FMS	24.82	22.9	541.1	1.96
2025-08-19	FMS	24.98	22.9	559.5	1.96
2025-08-20	FMS	25.18	22.9	566.6	1.96
2025-08-21	FMS	25.25	22.9	560.9	1.96
2025-08-22	FMS	25.61	22.9	576.0	1.96
2025-08-25	FMS	25.29	22.9	539.3	1.96
2025-08-26	FMS	25.48	22.2	558.5	1.96
2025-08-28	FMS	25.14	22.2	553.4	1.96
2025-08-29	FMS	25.68	22.2	584.2	1.96
2025-09-02	FMS	24.33	22.2	546.2	1.96
2025-09-03	FMS	24.37	22.2	1041.8	1.96
2025-09-04	FMS	24.33	22.2	1039.1	1.96
2025-09-05	FMS	24.77	22.2	1076.3	1.96
2025-09-08	FMS	25.10	22.2	1068.5	1.96
2025-09-09	FMS	25.30	22.2	1055.3	1.96
2025-09-10	FMS	24.87	22.2	1009.8	1.96
2025-09-11	FMS	25.26	22.2	1071.5	1.96
2025-09-12	FMS	24.96	22.2	1025.8	1.96
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	FMS	0.00	0.10	0.31
2025-08-18	FMS	0.00	0.31	0.31
2025-08-19	FMS	0.00	0.31	0.31
2025-08-20	FMS	0.00	0.31	0.31
2025-08-21	FMS	0.00	0.31	0.31
2025-08-22	FMS	0.00	0.31	0.31
2025-08-25	FMS	0.00	0.35	0.31
2025-08-26	FMS	0.00	0.35	0.31
2025-08-27	FMS	0.00	0.35	0.26
2025-08-28	FMS	0.00	0.35	0.26
2025-08-29	FMS	0.00	0.35	0.26
2025-09-02	FMS	0.00	0.26	0.26
2025-09-03	FMS	0.00	0.26	0.26
2025-09-04	FMS	0.00	0.26	0.26
2025-09-05	FMS	0.00	0.26	0.26
2025-09-08	FMS	0.00	0.91	0.26
2025-09-09	FMS	0.00	0.91	0.26
2025-09-10	FMS	0.00	0.91	0.26
2025-09-11	FMS	0.00	0.91	0.25
2025-09-12	FMS	0.00	0.91	0.25
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.52

Avg. EPS Est. Current Quarter

0.5

Avg. EPS Est. Next Quarter

0.63

Insider Transactions

Institutional Transactions

0.91

Beta

0.91

Average Sales Estimate Current Quarter

4725

Average Sales Estimate Next Quarter

4886

Fair Value

31.26

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

43.4

Max Drawdown 5-Year %

-69.2

Target Price

29.43

P/E

20.35

Forward P/E

9.94

PEG

1.01

P/S

0.69

P/B

0.94

P/Free Cash Flow

6.6

EPS

1.23

Average EPS Est. Cur. Y

1.96

EPS Next Y. (Est.)

2.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.39

Relative Volume

1.08

Return on Equity vs Sector %

-19.9

Return on Equity vs Industry %

-63.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1025.8

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 112445

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

stock quote shares FMS – Fresenius Medical Care AG ADR Stock Price stock today

news today FMS – Fresenius Medical Care AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG ADR yahoo finance google finance

stock history FMS – Fresenius Medical Care AG ADR invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

FMS – Fresenius Medical Care AG & Co. KGaA

Float Short %

0.25

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

0.1

EPS Last/This Y

EPS This/Next Y

1.03

Price

24.96

Target Price

29.43

Analyst Recom

2.7

Performance Q

-13.72

Relative Volume

1.08

Beta

0.91

Ticker: FMS

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	FMS	25.06	0.05	999.99	765
2025-08-18	FMS	24.83	0.03	0.40	738
2025-08-19	FMS	24.97	0.03	0.40	738
2025-08-20	FMS	25.19	0.03	1.00	745
2025-08-21	FMS	25.24	0.03	1.00	746
2025-08-22	FMS	25.6	0.03	999.99	750
2025-08-25	FMS	25.31	0.03	999.99	750
2025-08-26	FMS	25.48	0.03	999.99	750
2025-08-27	FMS	25.15	0.03	0.00	750
2025-08-28	FMS	25.18	0.03	0.00	750
2025-08-29	FMS	25.71	0.03	0.00	810
2025-09-02	FMS	24.32	0.03	0.00	810
2025-09-03	FMS	24.37	0.03	0.00	917
2025-09-04	FMS	24.32	0.03	0.00	917
2025-09-05	FMS	24.74	0.03	0.00	937
2025-09-08	FMS	25.09	0.03	0.01	1001
2025-09-09	FMS	25.3	0.02	0.28	1072
2025-09-10	FMS	24.88	0.04	0.01	1130
2025-09-11	FMS	25.28	0.03	0.36	1334
2025-09-12	FMS	24.97	0.04	0.00	1339
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	FMS	25.07	22.9	561.4	1.96
2025-08-18	FMS	24.82	22.9	541.1	1.96
2025-08-19	FMS	24.98	22.9	559.5	1.96
2025-08-20	FMS	25.18	22.9	566.6	1.96
2025-08-21	FMS	25.25	22.9	560.9	1.96
2025-08-22	FMS	25.61	22.9	576.0	1.96
2025-08-25	FMS	25.29	22.9	539.3	1.96
2025-08-26	FMS	25.48	22.2	558.5	1.96
2025-08-28	FMS	25.14	22.2	553.4	1.96
2025-08-29	FMS	25.68	22.2	584.2	1.96
2025-09-02	FMS	24.33	22.2	546.2	1.96
2025-09-03	FMS	24.37	22.2	1041.8	1.96
2025-09-04	FMS	24.33	22.2	1039.1	1.96
2025-09-05	FMS	24.77	22.2	1076.3	1.96
2025-09-08	FMS	25.10	22.2	1068.5	1.96
2025-09-09	FMS	25.30	22.2	1055.3	1.96
2025-09-10	FMS	24.87	22.2	1009.8	1.96
2025-09-11	FMS	25.26	22.2	1071.5	1.96
2025-09-12	FMS	24.96	22.2	1025.8	1.96
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	FMS	0.00	0.10	0.31
2025-08-18	FMS	0.00	0.31	0.31
2025-08-19	FMS	0.00	0.31	0.31
2025-08-20	FMS	0.00	0.31	0.31
2025-08-21	FMS	0.00	0.31	0.31
2025-08-22	FMS	0.00	0.31	0.31
2025-08-25	FMS	0.00	0.35	0.31
2025-08-26	FMS	0.00	0.35	0.31
2025-08-27	FMS	0.00	0.35	0.26
2025-08-28	FMS	0.00	0.35	0.26
2025-08-29	FMS	0.00	0.35	0.26
2025-09-02	FMS	0.00	0.26	0.26
2025-09-03	FMS	0.00	0.26	0.26
2025-09-04	FMS	0.00	0.26	0.26
2025-09-05	FMS	0.00	0.26	0.26
2025-09-08	FMS	0.00	0.91	0.26
2025-09-09	FMS	0.00	0.91	0.26
2025-09-10	FMS	0.00	0.91	0.26
2025-09-11	FMS	0.00	0.91	0.25
2025-09-12	FMS	0.00	0.91	0.25
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.52

Avg. EPS Est. Current Quarter

0.5

Avg. EPS Est. Next Quarter

0.63

Insider Transactions

Institutional Transactions

0.91

Beta

0.91

Average Sales Estimate Current Quarter

4725

Average Sales Estimate Next Quarter

4886

Fair Value

31.26

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

43.4

Max Drawdown 5-Year %

-69.2

Target Price

29.43

P/E

20.35

Forward P/E

9.94

PEG

1.01

P/S

0.69

P/B

0.94

P/Free Cash Flow

6.6

EPS

1.23

Average EPS Est. Cur. Y

1.96

EPS Next Y. (Est.)

2.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.39

Relative Volume

1.08

Return on Equity vs Sector %

-19.9

Return on Equity vs Industry %

-63.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1025.8

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 112445

stock quote shares FMS – Fresenius Medical Care AG & Co. KGaA Stock Price stock today

news today FMS – Fresenius Medical Care AG & Co. KGaA stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG & Co. KGaA yahoo finance google finance

stock history FMS – Fresenius Medical Care AG & Co. KGaA invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

SSU – SIGNA Sports United N.V.

Float Short %

0.16

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.02

Target Price

3.92

Analyst Recom

3.5

Performance Q

-96.71

Relative Volume

Beta

0.55

Ticker: SSU

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	SSU	0.0937	N/A	N/A	0
2025-08-18	SSU	0.0937	N/A	N/A	0
2025-08-19	SSU	0.0937	N/A	N/A	0
2025-08-20	SSU	0.0937	N/A	N/A	0
2025-08-21	SSU	0.0937	N/A	N/A	0
2025-08-22	SSU	0.0937	N/A	N/A	0
2025-08-25	SSU	0.0937	N/A	N/A	0
2025-08-26	SSU	0.0937	N/A	N/A	0
2025-08-27	SSU	0.0937	N/A	N/A	0
2025-08-28	SSU	0.0937	N/A	N/A	0
2025-08-29	SSU	0.0937	N/A	N/A	0
2025-09-02	SSU	0.0937	N/A	N/A	0
2025-09-03	SSU	0.0937	N/A	N/A	0
2025-09-04	SSU	0.0937	N/A	N/A	0
2025-09-05	SSU	0.0937	N/A	N/A	0
2025-09-08	SSU	0.0937	N/A	N/A	0
2025-09-09	SSU	0.0937	N/A	N/A	0
2025-09-10	SSU	0.0937	N/A	N/A	0
2025-09-11	SSU	0.0937	N/A	N/A	0
2025-09-12	SSU	0.0937	N/A	N/A	0
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.8

Max Drawdown 5-Year %

Target Price

3.92

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-1.08

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-137

Return on Equity vs Industry %

-170

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

stock quote shares SSU – SIGNA Sports United N.V. Stock Price stock today

news today SSU – SIGNA Sports United N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch SSU – SIGNA Sports United N.V. yahoo finance google finance

stock history SSU – SIGNA Sports United N.V. invest stock market

stock prices SSU premarket after hours

ticker SSU fair value insiders trading

SAP – SAP SE

Float Short %

0.17

Margin Of Safety %

Put/Call OI Ratio

1.04

EPS Next Q Diff

0.19

EPS Last/This Y

3.92

EPS This/Next Y

1.34

Price

257.2

Target Price

343.55

Analyst Recom

1.62

Performance Q

-14.77

Relative Volume

Beta

1.29

Ticker: SAP

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	SAP	277.83	1.20	0.65	41350
2025-08-18	SAP	276.06	1.48	0.74	28724
2025-08-19	SAP	274.25	1.46	1.66	29019
2025-08-20	SAP	272.5	1.45	0.95	29131
2025-08-21	SAP	269.24	1.42	0.22	29322
2025-08-22	SAP	271.03	1.38	0.26	29515
2025-08-25	SAP	270.42	1.37	0.79	29543
2025-08-26	SAP	269.86	1.37	1.51	29639
2025-08-27	SAP	275.37	1.38	1.26	29893
2025-08-28	SAP	275.19	1.39	2.76	30510
2025-08-29	SAP	272.07	1.41	0.36	30880
2025-09-02	SAP	266.13	1.39	1.18	31213
2025-09-03	SAP	270.91	1.38	1.15	31714
2025-09-04	SAP	272.08	1.39	13.12	31957
2025-09-05	SAP	269.14	1.39	0.46	32406
2025-09-08	SAP	270.16	1.34	0.30	32949
2025-09-09	SAP	271.5	1.30	4.82	33718
2025-09-10	SAP	260.45	1.27	1.07	35114
2025-09-11	SAP	258.14	1.10	1.29	36196
2025-09-12	SAP	257.22	1.04	0.32	36374
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	SAP	277.82	29.3	-671.5	7.03
2025-08-18	SAP	276.58	29.3	-626.3	7.03
2025-08-19	SAP	274.23	29.3	-707.2	7.03
2025-08-20	SAP	272.43	29.3	-794.4	7.03
2025-08-21	SAP	269.14	29.3	-780.4	7.03
2025-08-22	SAP	271.02	29.3	-621.8	7.03
2025-08-25	SAP	270.34	29.3	-673.1	7.03
2025-08-26	SAP	269.86	29.3	-713.2	7.03
2025-08-27	SAP	275.22	29.3	-18.0	7.03
2025-08-28	SAP	275.40	29.3	-242.1	7.03
2025-08-29	SAP	272.00	29.3	-401.8	7.03
2025-09-02	SAP	266.14	29.3	-642.7	7.03
2025-09-03	SAP	270.83	29.3	1947.4	7.03
2025-09-04	SAP	272.08	29.3	1764.2	7.03
2025-09-05	SAP	269.00	29.3	1254.6	7.03
2025-09-08	SAP	270.33	29.3	1614.3	7.03
2025-09-09	SAP	271.46	29.3	1676.3	7.03
2025-09-10	SAP	260.45	29.3	1122.1	7.03
2025-09-11	SAP	258.19	29.3	1396.0	7.03
2025-09-12	SAP	257.20	29.3	1465.3	7.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	SAP	0	-0.86	0.25
2025-08-18	SAP	0	-0.13	0.25
2025-08-19	SAP	0	-0.13	0.25
2025-08-20	SAP	0	-0.13	0.25
2025-08-21	SAP	0	-0.13	0.25
2025-08-22	SAP	0	-0.13	0.25
2025-08-25	SAP	0	-1.30	0.25
2025-08-26	SAP	0	-1.30	0.25
2025-08-27	SAP	0	-1.30	0.23
2025-08-28	SAP	0	-1.30	0.23
2025-08-29	SAP	0	-1.30	0.23
2025-09-02	SAP	0	-1.50	0.23
2025-09-03	SAP	0	-1.50	0.23
2025-09-04	SAP	0	-1.50	0.23
2025-09-05	SAP	0	-1.50	0.23
2025-09-08	SAP	0	-1.38	0.23
2025-09-09	SAP	0	-1.38	0.23
2025-09-10	SAP	0	-1.38	0.23
2025-09-11	SAP	0	-1.38	0.17
2025-09-12	SAP	0	-1.38	0.17
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.7

Avg. EPS Est. Current Quarter

1.72

Avg. EPS Est. Next Quarter

1.89

Insider Transactions

Institutional Transactions

-1.38

Beta

1.29

Average Sales Estimate Current Quarter

9103

Average Sales Estimate Next Quarter

9818

Fair Value

335.85

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

17.9

Max Drawdown 5-Year %

-48.8

Target Price

343.55

P/E

42.55

Forward P/E

30.7

PEG

1.49

P/S

7.67

P/B

6.22

P/Free Cash Flow

43.55

EPS

6.04

Average EPS Est. Cur. Y

7.03

EPS Next Y. (Est.)

8.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.22

Relative Volume

Return on Equity vs Sector %

-33.6

Return on Equity vs Industry %

-3.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.11

EBIT Estimation

1465.3

SAP SE

Sector: Technology

Industry: Software - Application

Employees: 108929

SAP SE, together with its subsidiaries, provides enterprise application and business solutions worldwide. It offers SAP S/4HANA that provides software capabilities for finance, risk and project management, procurement, manufacturing, supply chain and asset management, and research and development; SAP SuccessFactors solutions for human resources, including HR, time, payroll, talent and employee experience management, and analytics and planning; and spend management solutions that covers direct and indirect spend, travel and expense, and external workforce management. The company also provides SAP customer experience solutions; SAP Business Technology platform that enables customers and partners to build, integrate, and automate applications; and SAP Business Network, a business-to-business collaboration platform that helps digitalize key business processes across the supply chain and enables communication between trading partners. In addition, it offers SAP Signavio to help customers to discover, analyze, and understand their business process operations; industry solutions that provides customers and partners with industry-specific solutions; and SAP LeanIX to visualize their as-is enterprise architecture, assess interdependencies and the potential impact of IT modernization, and manage the transition toward the target landscape with established practices and a detailed roadmap. Further, the company provides WalkMe to execute workflows across various number of applications; SAP Enable Now, which offers e-learning content embedded in SAP workflows; Taulia solutions for working capital management to help businesses create and deliver the right cash flow strategy, and the flexibility to adjust it to meet liquidity challenges; and sustainability solutions and services. Additionally, it provides services and support solutions. SAP SE was founded in 1972 and is headquartered in Walldorf, Germany.

stock quote shares SAP – SAP SE Stock Price stock today

news today SAP – SAP SE stock forecast ,stock prediction 2023 2024 2025

marketwatch SAP – SAP SE yahoo finance google finance

stock history SAP – SAP SE invest stock market

stock prices SAP premarket after hours

ticker SAP fair value insiders trading

No more stocks to show

VJET – Voxeljet AG ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VJET

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

IMTX – Immatics N.V

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: IMTX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y